StockData
Artelo Biosciences, Inc. logo

Artelo Biosciences, Inc. (ARTL) KPIs and segments

ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.68−0.02 (-1.18%)

Close on Nov 17, 2026Market cap $1.13MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Artelo Biosciences's business

Coming soon

This tab will track the numbers specific to Artelo Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?